Schonfeld Strategic Advisors
MYOK

Schonfeld Strategic Advisors’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Schonfeld Strategic Advisors’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-17,087
Closed -$801K – 1654
2020
Q1 		$801K Buy
+17,087
New +$1.09M 0.05% 434
2019
Q4 		– Sell
-28,244
Closed -$1.47M – 1564
2019
Q3 		$1.47M Buy
+28,244
New +$1.5M 0.04% 385

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Avoro Capital Advisors
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Bellevue Group
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Schonfeld Strategic Advisors's MYOK Position: Q2 2020 in Review

Schonfeld Strategic Advisors sold out of MyoKardia, Inc. Common Stock (MYOK) in Q2 2020, closing a stake of 17,087 shares — an estimated $801K sold.

Schonfeld Strategic Advisors first reported a position in MYOK in Q3 2019 and held it in 2 quarters. The position peaked at $1.47M in Q3 2019. 235 funds tracked by Wall St. Rank hold MYOK as of Q2 2020.

  • Schonfeld Strategic Advisors reported no remaining MyoKardia, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 17,087 MyoKardia, Inc. Common Stock shares in Q2 2020, an estimated $801K.
  • Schonfeld Strategic Advisors first reported a position in MyoKardia, Inc. Common Stock in Q3 2019 and held it in 2 quarters.
  • Schonfeld Strategic Advisors's MyoKardia, Inc. Common Stock position peaked at $1.47M in Q3 2019.
  • 235 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q2 2020.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.